MYO1D expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.990600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.096800E-01
Normal-vs-Stage2
1.870980E-01
Normal-vs-Stage3
7.252200E-01
Normal-vs-Stage4
2.150200E-02
Stage1-vs-Stage2
5.863600E-01
Stage1-vs-Stage3
6.481800E-01
Stage1-vs-Stage4
1.052480E-02
Stage2-vs-Stage3
3.402400E-01
Stage2-vs-Stage4
1.596270E-02
Stage3-vs-Stage4
1.822000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.059800E-01
Normal-vs-AfricanAmerican
2.955500E-02
Normal-vs-Asian
4.977200E-01
Caucasian-vs-AfricanAmerican
9.401600E-02
Caucasian-vs-Asian
9.465200E-01
AfricanAmerican-vs-Asian
1.959220E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.294400E-01
Normal-vs-Female
1.856550E-01
Male-vs-Female
8.071800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.326200E-01
Normal-vs-Age(41-60Yrs)
7.646300E-02
Normal-vs-Age(61-80Yrs)
2.890000E-01
Normal-vs-Age(81-100Yrs)
1.149950E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.362100E-02
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.322200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.468100E-02
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.059600E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.287400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.827800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.880000E-01
Normal-vs-Daily Drinker
5.797600E-01
Normal-vs-Weekly Drinker
2.478000E-01
Normal-vs-Occasional Drinker
1.429020E-01
Normal-vs-Social Drinker
1.567380E-01
Non Drinker-vs-Daily Drinker
1.649620E-01
Non Drinker-vs-Weekly Drinker
7.200800E-01
Non Drinker-vs-Occasional Drinker
3.021600E-01
Non Drinker-vs-Social Drinker
1.463010E-01
Daily Drinker-vs-Weekly Drinker
1.202750E-01
Daily Drinker-vs-Occasional Drinker
2.330500E-02
Daily Drinker-vs-Social Drinker
1.409600E-02
Weekly Drinker-vs-Occasional Drinker
5.878800E-01
Weekly Drinker-vs-Social Drinker
3.590400E-01
Occasional Drinker-vs-Social Drinker
6.150400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.945420E-01
Normal-vs-Grade 2
4.349600E-02
Normal-vs-Grade 3
4.688300E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.751000E-01
Grade 1-vs-Grade 3
1.030980E-01
Grade 1-vs-Grade 4
1.945420E-01
Grade 2-vs-Grade 3
4.645400E-01
Grade 2-vs-Grade 4
4.349600E-02
Grade 3-vs-Grade 4
4.688300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.676200E-01
Normal-vs-NonDiabetic
1.880760E-01
Diabetic-vs-NonDiabetic
3.613600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.141760E-01
Normal-vs-NoPancreatitis
2.409800E-01
Pancreatitis-vs-NoPancreatitis
8.430400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.718640E-01
Normal-vs-N1
2.014000E-01
N0-vs-N1
1.562820E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.530830E-01
Normal-vs-TP53-NonMutant
2.473200E-01
TP53-Mutant-vs-TP53-NonMutant
3.596200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
